Showing results (1721-1730 of 2,593) with videos related to

Sort By:
Pageof 260
Gut|July 20, 2014
Surveillance in patients with long-segment Barrett's oesophagus: a cost-effectiveness analysisF Kastelein, S van Olphen, E W Steyerberg, et al.
European Journal of Cancer (Oxford, England : 1990)|July 30, 2015
Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guidelineAlexander Stratigos, Claus Garbe, Celeste Lebbe, et al.
JIMD Reports|June 8, 2026
Patient Preferences in Neuromuscular Diseases: Insights for Future Drug DevelopmentAura Cecilia Jimenez-Moreno, Alasdair Blain, Cathy Anne Pinto, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 13, 2019
Understanding Patients' Preferences: A Systematic Review of Psychological Instruments Used in Patients' Preference and Decision StudiesSelena Russo, Chiara Jongerius, Flavia Faccio, et al.
European Journal of Cancer (Oxford, England : 1990)|October 29, 2011
The CareGiver Oncology Quality of Life questionnaire (CarGOQoL): development and validation of an instrument to measure the quality of life of the caregivers of patients with cancerPatricia Minaya, Karine Baumstarck, Julie Berbis, et al.
The Journal of Nervous and Mental Disease|February 1, 1996
Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in BrazilC S Grob, D J McKenna, J C Callaway, et al.
Blood Advances|September 16, 2020
Panobinostat and decitabine prior to donor lymphocyte infusion in allogeneic stem cell transplantationBurak Kalin, Yvette van Norden, Michel van Gelder, et al.
European Journal of Cancer (Oxford, England : 1990)|December 29, 2015
Survival of patients with advanced metastatic melanoma: The impact of novel therapiesSelma Ugurel, Joachim Röhmel, Paolo A Ascierto, et al.
Multiple Sclerosis and Related Disorders|May 19, 2026
Complementary therapies for multiple sclerosis: Scoping review with evidence gap mapJesus Lopez-Alcalde, Yuqian Yan, Claudia Canella, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2025
Patient-reported outcomes with adjuvant nivolumab versus placebo after complete resection of stage IIB/C melanoma in the randomized phase 3 CheckMate 76 K trialJohn M Kirkwood, Peter Mohr, Christoph Hoeller, et al.
Pageof 260